Enhance the safety and efficacy of your biomedical device by evaluating its antimicrobial properties and behavior in realistic physiological environments.Industrial gap/problem coveredInfections within the hospital environment and associated with biomedical devices are a significant public health co...

Precision Delivery, Tailored Solutions: Peptide-Functionalized Nanoparticles for Next-Generation Therapies.Industrial gap coveredOne of the greatest challenges in nanomedicine is the delivery of therapeutically relevant amounts of drugs to specific body tissues or organs, hampering the development o...

Revolutionize disease treatment with our new Cutting-Edge Solution — precise enzyme-loaded nanovesicles, offering targeted therapies for various disorders with optimal efficacy and safety.Industrial gap/problem coveredNanovesicles are ideal vehicles for many biomolecules, including enzymes. and migh...

Design advanced antimicrobial nanoparticles for comprehensive, affordable wound treatment, addressing multiple aspects of infection with enhanced effectiveness.Industrial gap/problem coveredThere are several antimicrobial materials on the market to prevent or treat microbial infections. Despite the...

Fast-track your nanomedicine’s path to market with NANBIOSIS: tailored preclinical studies, cutting-edge imaging, and comprehensive analytics, all while ensuring ethical compliance and regulatory adherence.Industrial problem/gap coveredOne of the causes that increase the time to market of nanotherap...

Accelerate your nanomedicine’s journey to market with NANBIOSIS: tailored in vitro characterization services ensuring preclinical validation success, saving crucial time in the development process.Industrial problem/gap covered One of the causes that increases the time required to reach the mar...

Fast-track nanotherapeutics to market with NANBIOSIS – expert characterization studies tailored for nanomedicines ensure rapid regulatory approval.Industrial problem/gap coveredOne of the causes that increases the time required to reach the market in nanotherapeutics is the preclinical validation. T...

This brand new Cutting Edge Biomedical Solution allows you to obtain customized recombinant proteins and a wide proteomic characterization.Industrial gap/problem coveredThe usability of recombinant proteins across diverse applications largely depends on their similarity to physiological counterparts...

Revolutionizing healthcare with recombinant proteins — unleashing safe, targeted drug delivery and tissue regeneration for groundbreaking therapeutic treatments.Industrial gap/problem coveredRecombinant proteins can be engineered to be used as effective, safe, non-invasive and cell selective nanomat...

Efficiently develop anti-peptide antibodies for precise protein targeting and post-translational modification detection.Industrial gap/problem coveredDeveloping anti-protein antibodies can be costly and often requires access to the target protein itself. In cases where the protein is unavailable or...